Targeting interleukin (IL)-4/IL-13 in immune checkpoint inhibitor-induced bullous pemphigoid: a cautionary note on the beneficial effect of T helper 2 immunity in melanoma and immunotherapy
British Journal of Dermatology · 2023
DOI: 10.1093/bjd/ljad324 ↗Kurz gefasst
Leserbrief in der Zeitschrift British Journal of Dermatology, 2023. Verfasst von Christian F Guerrero-Juarez und 2 weiteren Autor:innen. Beteiligte Einrichtung: Carle Illinois College of Medicine, University of Illinois, Urbana-Champaign, Urbana. Hauptthemen laut MEDLINE: Pemphigoid, Bullous, Melanoma. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 4 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIH HHS, National Institute of Health.
Abstract (Originalsprache)
The use of dupilumab has been suggested in the treatment of immune checkpoint inhibitor (ICI)-induced bullous pemphigoid. In this letter, we express caution with the targeted inhibition of the Th2 pathway given current evidence suggesting the beneficial effect of the Th2 response, particularly eosinophilia, to ICI responses, particularly in melanoma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Carle Illinois College of Medicine, University of Illinois, Urbana-Champaign, Urbana.
- Department of Dermatology, Rush University Medical Center, Chicago.
- Department of Internal Medicine, Rush University Medical Center, Chicago, IL, USA.
ORCID-Profile: Kyle T Amber
Förderung
- NIH HHS
- National Institute of Health
Zitieren
APA
Guerrero-Juarez, C. F., Goyal, P. K., & Amber, K. T. (2023). Targeting interleukin (IL)-4/IL-13 in immune checkpoint inhibitor-induced bullous pemphigoid: a cautionary note on the beneficial effect of T helper 2 immunity in melanoma and immunotherapy. British Journal of Dermatology. https://doi.org/10.1093/bjd/ljad324
Vancouver
Guerrero-Juarez CF, Goyal PK, Amber KT. Targeting interleukin (IL)-4/IL-13 in immune checkpoint inhibitor-induced bullous pemphigoid: a cautionary note on the beneficial effect of T helper 2 immunity in melanoma and immunotherapy. British Journal of Dermatology. 2023. doi:10.1093/bjd/ljad324
BibTeX
@article{GuerreroJuarez2023,
author = {Guerrero-Juarez, Christian F and Goyal, Parul K and Amber, Kyle T},
title = {Targeting interleukin (IL)-4/IL-13 in immune checkpoint inhibitor-induced bullous pemphigoid: a cautionary note on the beneficial effect of T helper 2 immunity in melanoma and immunotherapy},
journal = {British Journal of Dermatology},
year = {2023},
doi = {10.1093/bjd/ljad324}
}
EUVIMED